Dr Harriette Van Spall (McMaster University, Hamilton, CA) and Dr Deepak L Bhatt (Brigham and Women's Hospital, Boston, MA, US) discussed the latest data on the benefits of SGLT1/2 inhibition across the full spectrum of ejection fraction, including HFpEF.

Recorded remotely from Boston and Hamilton, 2021. 

Editor: Mirjam Boros